Pliant Therapeutics enters $50M at-the-market equity facility with Leerink; terminates prior Cantor agreement

PLIANT THERAPEUTICS, INC.

Entered Sales Agreement with Leerink Partners for ATM offering of common stock up to $50 million.
Terminated 2021 Sales Agreement with Cantor Fitzgerald; no penalties incurred and no shares had been sold under it.
New ATM program provides continued market-based equity financing flexibility.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.